drugset / Trial / NCT00743470
A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult Subjects
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to study the safety, tolerability and pharmacokinetics of rifabutin dosing with lopinavir/ritonavir tablets in healthy volunteers.
Timeline
- Start
- 2008-08
- Primary completion
- 2008-10
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rifabutin | Small molecule | 150 mg | — |
| Subject | lopinavir/ritonavir | Unknown | — | — |